Results 221 to 230 of about 33,889 (327)

Cardiovascular disease burden in patients with urological cancers: The new discipline of uro‐cardio‐oncology [PDF]

open access: diamond
Yi Zheng   +11 more
openalex   +1 more source

Crucial Contribution of BACH1 to Bladder Cancer Progression via Upregulating Epithelial‐Mesenchymal Transition Pathway

open access: yesCancer Science, EarlyView.
BACH1 is associated with poor prognosis in BC patients and plays a critical role in promoting tumor progression and metastasis. Furthermore, we elucidated the mechanism by which BACH1 facilitates tumor progression and metastasis, primarily through activation of the EMT pathway. These findings suggest that BACH1 may serve as a novel prognostic biomarker
Tomoya Hatayama   +19 more
wiley   +1 more source

Changes in brain white matter structure are associated with urine proteins in urologic chronic pelvic pain syndrome (UCPPS): A MAPP Network study [PDF]

open access: yes, 2018
Andriole, Gerald L   +10 more
core   +2 more sources

Extraperitoneal single‐site robot‐assisted radical prostatectomy with extended pelvic lymph node dissection: technique and experience

open access: yes
BJU International, Volume 135, Issue 4, Page 700-705, April 2025.
Yubo Wang   +10 more
wiley   +1 more source

Longitudinal Impact of Urinary Diversion on Health‐Related Quality of Life After Radical Cystectomy: A Multicenter Study in Japan

open access: yesCancer Science, EarlyView.
This multicenter prospective study examined the impact of urinary diversion on HRQOL among bladder cancer patients who underwent radical cystectomy. Evaluation using the BCI clarified changes in HRQOL related to urinary, bowel, and sexual domains before surgery and at 3, 6, and 12 months postoperatively.
Shuhei Yamada   +32 more
wiley   +1 more source

STATISTICAL ANALYSIS OF THE UROLOGICAL DISEASES DURING RECENT SIX YEARS AT THE DEPARTMENT OF UROLOGY IN THE UNIVERSITY OF TOKYO

open access: bronze, 1970
Hisao Takayasu   +8 more
openalex   +2 more sources

Effectiveness and Safety of Radium‐223 for Bone‐Metastatic Castration‐Resistant Prostate Cancer: The KYUCOG‐1901 Study

open access: yesCancer Science, EarlyView.
The KYUCOG‐1901 prospective multicenter study evaluated radium‐223 in 93 Japanese patients with bone‐metastatic castration‐resistant prostate cancer. Ra‐223 was well tolerated, produced meaningful declines in ALP, and yielded a median overall survival of 23.0 months. Early initiation in patients with lower disease burden and integration with subsequent
Masaki Shiota   +12 more
wiley   +1 more source

Home - About - Disclaimer - Privacy